Company performance
Current Price
as of Jan 07, 2025$2.23
P/E Ratio
N/A
Market Cap
$72.07M
- RMTI
Description
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in 1996 and is headquartered in Wixom, MI.
Metrics
Overview
- HQWixom, MI
- SectorHealth Technology
- IndustryMedical Specialties
- TickerRMTI
- Price$2.23-1.11%
Trading Information
- Market cap$72.07M
- Float86.74%
- Average Daily Volume (1m)491,367
- Average Daily Volume (3m)724,058
- EPS-$0.06
Company
- Revenue$98.92M
- Rev growth (1yr)19.12%
- Net income$1.43M
- Gross margin22.03%
- EBITDA margin8.75%
- EBITDA$2.48M
- EV$124.61M
- EV/Revenue1.26
- P/EN/A
- P/S0.73
- P/B2.47
Documents
SEC Filings
Earnings Calls
Factset Street Account